Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clobetasone is a synthetic corticosteroid used primarily as a topical medication to treat skin conditions such as eczema, dermatitis, and psoriasis. It is also sometimes used for certain ophthalmologic conditions like dry eyes. As a moderate-potency steroid (less potent than clobetasol), it works by binding to cytoplasmic glucocorticoid receptors in dermal and intradermal cells. This action induces inhibitory proteins that decrease the activity of inflammatory mediators such as prostaglandins, kinins, histamine, and liposomal enzymes. The result is reduced swelling (edema), redness (erythema), itching (pruritus), and irritation at the site of application[1][3][8]. Clobetasone may be combined with other agents such as antibiotics or antifungals in some formulations (e.g., Trimovate)[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clobetasone.